Company Filing History:
1 out of 59 
1 out of 3 
1 out of 1,001 
Years Active: 1990-2007
Title: Innovator Tetsuji Sudoh: Pioneering Advances in Medical Peptides
Introduction: Tetsuji Sudoh is a notable inventor based in Tokyo, Japan, recognized for his contributions in the field of biochemistry. With a total of two patents, Sudoh's work focuses on the development of physiologically active polypeptides that have promising applications in medicine.
Latest Patents: Sudoh's latest patents include groundbreaking discoveries in the realm of human-derived polypeptides and DNA. The first patent reveals a physiologically active polypeptide derived from the human brain. This polypeptide demonstrates exceptional qualities such as smooth muscle relaxation activity, diuretic or natriuretic activity, and vasodepressor activity. These characteristics make it valuable for treating various circulation diseases, including cardiac edema, nephric edema, hepatic edema, pulmonary edema, hypertension, congestive heart failure, and acute and chronic renal failure. The second patent introduces a novel physiologically active peptide, defined by a specific formula that offers innovative therapeutic potential.
Career Highlights: Throughout his career, Tetsuji Sudoh has made significant strides in the field of medical science, particularly through his research and patenting of unique peptides. His work continues to influence advancements in medical treatments and therapeutics.
Collaborations: Sudoh has worked alongside esteemed colleagues, including Hisayuki Matsuo and Kenji Kangawa, contributing to extensive research projects and enhancing the potential impact of his inventions. Additionally, he has collaborated with organizations such as Daiichi Pure Chemicals Co., Ltd., further demonstrating his commitment to innovation in healthcare.
Conclusion: Tetsuji Sudoh's inventive contributions to the field of biochemistry and medicine are marked by his patents on physiologically active polypeptides and their applications. His ongoing research and collaborations hold promise for future advancements in treating critical health conditions, solidifying his status as a leading figure in medical innovation.